Citations with the tag: INTRAVENOUS therapy -- Safety measures
Results 1 - 11
- Risk of giving intravenous aminophylline to acutely ill patients receiving maintenance treatment with theophylline.
Stewart, M. Felicity; Barclay, Joyce; Warburton, Ray // British Medical Journal (Clinical Research Edition); 2/11/1984, Vol. 288 Issue 6415, p450
Focuses on the risk of giving intravenous aminophylline to acutely ill patients receiving maintenance treatment of theophylline in Great Britain. Conditions for the efficacy of theophylline; Toxicity of the drug during acute illnesses; Significance of theophylline concentration maintenance for...
- Have a 'don't-interrupt' policy when giving IV.
Stewart, M. Felicity; Barclay, Joyce; Warburton, Ray // ED Nursing; May2009, Vol. 12 Issue 7, p79
The article presents a recommendation from the American Society of Health-Systems Pharmacists that emergency nurses should not be interrupted or disturbed during intravenous drug administration.
- False hyperglycemia from IV dextrose.
R.M.D. // Cortlandt Forum; 3/25/96, Vol. 9 Issue 3, p138
Recommends preventive measures in caring for a hospitalized patient with high blood glucose. Use of finger-stick glucose monitor to check the blood glucose before administering intravenous dextrose; Insulin administration.
- Call for all staff administering drugs to undergo a maths test.
R.M.D. // Nursing Standard; 11/26/2008, Vol. 23 Issue 12, p7
The article reports that nurses could be required to achieve a perfect score on a maths examination before being allowed to administer drugs intravenously. The introduction of the maths requirement by Margaret Connolly, lead nurse for specialist and advanced practice at NHS (National Health...
- Put a stop to IV med errors with 4 practices.
R.M.D. // ED Nursing; May2009, Vol. 12 Issue 7, p78
The article presents recommendations for preventing intravenous (IV) medication administration errors by Bona E. Benjamin, director of medication-use quality improvement at the American Society of Health-System Pharmacists (ASHP). An ASHP study found that IV drug errors were more likely to cause...
- A Virtual Clean Room to Teach USP 797 Regulations for Intravenous Medications.
Patel, Sheetal; Vincent, Ashley H.; Abel, Steven R.; Jacobs, Carolyn M.; Dunlop, Steven R.; Seibert, Megan // American Journal of Pharmaceutical Education; Jan2011, Vol. 75 Issue 1, p1
Objective. To provide a virtual environment for pharmacy students to learn United States Pharmacopeia Chapter 797 (USP 797) requirements, while recognizing the role of pharmacists in the safe use of intravenous (IV) medications. Design. A virtual laboratory was created that included stations for...
- Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
Mattiuzzi, Gloria N.; Cortes, Jorge; Alvarado, Gladys; Verstovsek, Srdan; Koller, Charles; Pierce, Sherry; Blamble, Deborah; Faderl, Stefan; Lianchun Xiao; Hernandez, Mike; Kantarjian, Hagop // Supportive Care in Cancer; Jan2011, Vol. 19 Issue 1, p19
Purpose: To compare the efficacy and safety of voriconazole with itraconazole as prophylaxis in leukemia patients. Methods: Open-label, randomized study. Patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome undergoing induction chemotherapy or first salvage were...
- Safety and Efficacy of Intravenous Iron Therapy in Postnatal Patients with Iron Deficiency Anemia.
Kouser, Shaheen; Kouser, Shahnaz; Malik, Mariam; Malik, Ahmad // Journal of South Asian Federation of Obstetrics & Gynecology; Jan-Apr2011, Vol. 3 Issue 1, p25
Objective: This prospective study was conducted to establish safety and efficacy of intravenous iron therapy in postnatal anemic patients. Results: Around 217 anemic women were included in the study. Most of these patients (82.2%) were of 21 to 30 years of age having parity of 2 to 4 (53.9%)....
- Needle-Free diluent technology.
Sanfilippo, Christophe // Pharmaceutical Technology Europe; Jan2010, Vol. 22 Issue 1, p28
The article reports on the concept of Needle-Free kit created by Bioluz and Technoflex Inc. It states that the concept is in response to the Food & Drug Administration (FDA) and the National Health Service (NHS)'s recommendations in preventing healthcare staff from needle-stick injuries in the...
- Safety Profile of Biological Intravenous Therapy in a Rheumatoid Arthritis Patients Cohort. Clinical Nursing Monitoring (Sebiol Study).
Corominas, Hèctor; Sánchez-Eslava, Lucinda; García, Guadalupe; Padró, Isabel; Aimarich, Cristina; Gonzàlez, Joana; Franco, Maria; Mur, Emilia; Sanchez, Silvia; Roldán, Glòria; Iniesta, Silvia; Sesma, Montse; Martín, Josefina; Rodriguez, Mari Carmen; Capellan, Maria Rosa; Gosálvez, Coral; Garcia-Diaz, Silvia; Sáez, Encarnación; Luna, Yolanda; Plana, Pilar // Reumatologia Clinica; mar/abr2013, Vol. 9 Issue 2, p80
Introduction: The biologics used in the management of rheumatoid arthritis (RA) in recent years have comprehensively permitted to understand their security, as shown in registries such as BIOBADASER. The present manuscript represents an observational cohort study to describe the safety...
- NICE backs down on PH guidance.
Corominas, Hèctor; Sánchez-Eslava, Lucinda; García, Guadalupe; Padró, Isabel; Aimarich, Cristina; Gonzàlez, Joana; Franco, Maria; Mur, Emilia; Sanchez, Silvia; Roldán, Glòria; Iniesta, Silvia; Sesma, Montse; Martín, Josefina; Rodriguez, Mari Carmen; Capellan, Maria Rosa; Gosálvez, Coral; Garcia-Diaz, Silvia; Sáez, Encarnación; Luna, Yolanda; Plana, Pilar // GP: General Practitioner; 4/10/2009, p8
The article reports on the plan of the National Institute for Clinical Excellence (NICE) to withdraw draft guidance for pulmonary hypertension (PH) in Great Britain. This is attributed to the appeal of the UK Pulmonary Hypertension Association (PHA-UK) when NICE made recommendations on PH drugs...